198 related articles for article (PubMed ID: 14735184)
81. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors.
Horvath P; Beckert S; Königsrainer A; Nadalin S; Königsrainer I
J Visc Surg; 2019 Dec; 156(6):475-484. PubMed ID: 31324533
[TBL] [Abstract][Full Text] [Related]
82. Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Chayahara N; Tamura T; Yamamori M; Kadowaki Y; Okuno T; Miki I; Tsuda M; Nishisaki H; Maeda T; Inoue Y; Okumura K; Azuma T; Kasuga M; Sakaeda T; Hirai M
Am J Clin Oncol; 2009 Feb; 32(1):56-60. PubMed ID: 19194126
[TBL] [Abstract][Full Text] [Related]
83. 5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study.
Fried G; Tsalik M; Stein M; Dale J; Haim N
Cancer Chemother Pharmacol; 1995; 35(5):437-40. PubMed ID: 7850927
[TBL] [Abstract][Full Text] [Related]
84. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil.
Aschele C; Debernardis D; Bandelloni R; Cascinu S; Catalano V; Giordani P; Barni S; Turci D; Drudi G; Lonardi S; Gallo L; Maley F; Monfardini S
Ann Oncol; 2002 Dec; 13(12):1882-92. PubMed ID: 12453856
[TBL] [Abstract][Full Text] [Related]
85. Carcinoma of the jejunum with multideposit peritoneal seeding, resection and intraperitoneal chemotherapy.
Innis M; Sandiford N; Shenoy RK; Prussia PR; Zbar A
West Indian Med J; 2005 Sep; 54(4):242-6. PubMed ID: 16312191
[TBL] [Abstract][Full Text] [Related]
86. A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinoma.
O'Byrne KJ; Philip PA; Propper DJ; Braybrooke JP; Saunders MP; Bates NP; Taylor MA; Madigan D; Ganesan TS; Talbot DC; Harris AL
Ann Oncol; 1999 Aug; 10(8):981-3. PubMed ID: 10509162
[TBL] [Abstract][Full Text] [Related]
87. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
88. Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.
André T; Louvet C; Raymond E; Tournigand C; de Gramont A
Ann Oncol; 1998 Nov; 9(11):1251-3. PubMed ID: 9862058
[TBL] [Abstract][Full Text] [Related]
89. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
90. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.
Bretcha-Boix P; Farré-Alegre J; Sureda M; Dussan C; Pérez Ruixo JJ; Brugarolas Masllorens A
Clin Transl Oncol; 2010 Jun; 12(6):437-42. PubMed ID: 20534399
[TBL] [Abstract][Full Text] [Related]
91. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
[TBL] [Abstract][Full Text] [Related]
92. Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Sobrero A; Zaniboni A; Frassineti GL; Aschele C; Guglielmi A; Giuliani R; Ravaioli A; Lanfranco C; Caroti C; Arnoldi E; Barni S; Gallo L; Pessi MA; Turci D; Cortesi E; Grossi F; Frontini L; Piazza E; Bruzzi P; Labianca R
Ann Oncol; 2000 Nov; 11(11):1413-20. PubMed ID: 11142481
[TBL] [Abstract][Full Text] [Related]
93. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
94. Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Ishikawa K; Makuuchi H; Murayama C
Oncology; 2009; 76(5):338-41. PubMed ID: 19307740
[TBL] [Abstract][Full Text] [Related]
95. Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
Jeon Y; Park EJ; Lim JH; Baik SH
World J Surg Oncol; 2019 Dec; 17(1):214. PubMed ID: 31829188
[TBL] [Abstract][Full Text] [Related]
96. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.
Van Cutsem E; Hoff PM; Harper P; Bukowski RM; Cunningham D; Dufour P; Graeven U; Lokich J; Madajewicz S; Maroun JA; Marshall JL; Mitchell EP; Perez-Manga G; Rougier P; Schmiegel W; Schoelmerich J; Sobrero A; Schilsky RL
Br J Cancer; 2004 Mar; 90(6):1190-7. PubMed ID: 15026800
[TBL] [Abstract][Full Text] [Related]
97. Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes.
Ornella MSC; Badrinath N; Kim KA; Kim JH; Cho E; Hwang TH; Kim JJ
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190310
[TBL] [Abstract][Full Text] [Related]
98. First experience with
Larsen SG; Graf W; Mariathasan AB; Sørensen O; Spasojevic M; Goscinski MA; Selboe S; Lundstrøm N; Holtermann A; Revheim ME; Bruland ØS
Front Med (Lausanne); 2023; 10():1070362. PubMed ID: 36936230
[TBL] [Abstract][Full Text] [Related]
99. Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer.
Kim YJ; Kim CH
Ann Coloproctol; 2021 Dec; 37(6):425-433. PubMed ID: 34961304
[TBL] [Abstract][Full Text] [Related]
100. Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients.
Larsen SG; Goscinski MA; Dueland S; Steigen SE; Hofsli E; Torgunrud A; Lund-Iversen M; Dagenborg VJ; Flatmark K; Sorbye H
Br J Cancer; 2022 Mar; 126(5):726-735. PubMed ID: 34887523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]